CD274 and neoplasm: Programmed death-ligand 1 (PD-L1), also known as B7 homolog 1 (B7-H1) or CD274, is a major obstacle to antitumor immunity because it confers resistance to tumor-reactive T cells when bound to its receptor PD-1 (CD279).